Latest vaccine data is even better than we had hoped
The two vaccines approved and in use in Britain showed high efficacy rates in trials, but it takes time for data to creep through on efficacy in the real-world. We are, however, getting the first figures trickling through. This morning comes a paper evaluating the effectiveness of the Pfizer-BioNTech and AstraZeneca-Oxford vaccines in preventing hospitalisation rates in the Scottish population, using a dataset that covers 5.4 million people, 99 per cent of the population. The Eave II study, led by the University of Edinburgh, followed the 650,000 people who received the Pfizer vaccine between 8 December and 15 February and the 490,000 people who received the AstraZeneca vaccine between 4